We were able to generate rapid in vivo tumor growth in NOD/SCID mice with only ten thousand of CD133+/CD44+-positive CSCs from the bulk cultures of 22Rv1 cells, whereas ten million of 22Rv1 cells from unsorted bulk cultures are generally required to successfully generate rapid tumor growth in the same strain of mice. The gene discussed is PROM1; the disease is neoplasm.